PharmacoEconomics

Cost Effectiveness of Influenza Vaccination in Older Adults: A Critical Review of Economic Evaluations for the 50- to 64-Year Age Group
pp. 439-450(12)
Authors: Newall, Anthony T.; Kelly, Heath; Harsley, Stuart; Scuffham, Paul A.

Pharmacoeconomic Considerations in Treating Actinic Keratosis
pp. 451-464(14)
Authors: Neidecker, Marjorie V.; >Mary Lynn Davis-Ajami,; Balkrishnan, Rajesh; Feldman, Steven R.

Holistic Preferences for 1-Year Health Profiles Describing Fluctuations in Health: The Case of Chronic Obstructive Pulmonary Disease
pp. 465-477(13)
Authors: Mölken, Maureen P.M.H. Rutten-van; Hoogendoorn, Martine; Lamers, Leida M.

Economic Outcomes Associated with Microvascular Complications of Type 2 Diabetes Mellitus: Results from a US Claims Data Analysis
pp. 479-490(12)
Authors: Pelletier, Elise M.; Shim, Boyung; Ben-Joseph, Rami; Caro, J. Jaime

Converting the SF-12 into the EQ-5D: An Empirical Comparison of Methodologies
pp. 491-505(15)
Authors: Chuang, Ling-Hsiang; Kind, Paul

Determinants of Direct Cost Differences among US Employees with Major Depressive Disorders Using Antidepressants
pp. 507-517(11)
Authors: Birnbaum, Howard G.; Ben-Hamadi, Rym; Greenberg, Paul E.; Hsieh, Matthew; Tang, Jackson; Reygrobellet, Camille

How to Deal with Cost Differences at Baseline
pp. 519-528(10)
Authors: van Asselt, Antoinette D.I.; van Mastrigt, Ghislaine A.P.G.; Dirksen, Carmen D.; Arntz, Arnoud; Severens, Johan L.; Kessels, Alfons G.H.